We all know about the high cost of drugs, especially cancer drugs. For the most part, the high cost is associated with the years and years of costly research that goes into developing and testing a drug for its efficacy and safety.
But these high drug prices are having a negative impact on hospitals, causing them to cut staff and limit services, which ultimately puts patients at risk.
Bear in mind, this is primarily an issue in the United States, as most other countries control the cost of medications. Most other countries also invest in the up-front research required to develop medicines.
It's a complex issue, but something we need to watch as prices are going up many times the rate of inflation. As hospitals suffer, the battle over health insurance continues - a solution will need to come soon.
Read more about this issue in The Truth About Cancer.